🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immunologic Deficiency Syndromes

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV NCT06274632NA2 sites📍 Miami📍 Houston Massachusetts General Hospital · Tests: ADELANTE An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites📍 Bullhead City📍 Huntington Park📍 St. Petersburg Grifols Therapeutics LLC · Tests: Xembify, Placebo A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Immuno-virological Evaluation of Persons Living With HIV (PLWH) NCT05973825NA1 site📍 Ghent University Hospital, Ghent · Tests: Leucapheresis Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) NCT04301076Phase 119 sites📍 Atlanta📍 Atlanta📍 City of Saint Peters National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640Phase 29 sites📍 Los Angeles📍 San Francisco📍 Indianapolis New York Medical College · Tests: viral specific cytotoxic t-lymphocytes Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein NCT06441123n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood Sampling Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) NCT05071222Phase 1, Phase 21 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: ARTEGENE drug product A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… A Mobile Gaming App to Improve Adherence to PrEP NCT05762705NA3 sites📍 Boston📍 Jackson📍 Providence Rhode Island Hospital · Tests: Multilevel Gaming Adherence Intervention, Treatment as Usual + Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75 NCT07388394NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: interview with advanced practice nurse EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653Phase 28 sites📍 Los Angeles📍 San Francisco📍 Baltimore New York Medical College · Tests: cytotoxic t-lymphocytes Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial NCT05183854Phase 21 site📍 Salt Lake City University of Utah · Tests: Pneumococcal 20-valent Conjugate Vaccine, Pneumococcal Polyvalent Vaccine Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) NCT06666322Phase 2, Phase 32 sites📍 Kampala📍 Mbarara David Boulware · Tests: Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2, Turletricin Injec… Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital NCT07299500n/a1 site📍 Strasbourg University Hospital, Strasbourg, France A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE) NCT07001280n/a22 sites📍 Phoenix📍 Miami📍 Saint Charles CSL Behring · Tests: No intervention SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION NCT06248957n/a1 site📍 Stockholm Karolinska Institutet · Tests: Immunomodulation Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older NCT05858034NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: Customized activity plan, Customized nutrition plan The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function NCT03240328Phase 11 site📍 Guangzhou Guangzhou 8th People's Hospital · Tests: CAR-T cells Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. NCT04160455n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: expression of a panel Reducing Systemic Inflammation in People on Antiretroviral Therapy NCT07030920Phase 21 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Fostemsavir Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care NCT05241990NA3 sites📍 San Diego📍 Boston📍 Chapel Hill Johns Hopkins University · Tests: Practice Facilitation, Alcohol Stepped Care TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children NCT04414046Phase 21 site📍 St. Petersburg Johns Hopkins All Children's Hospital · Tests: Haploidentical Hematopoietic Cell Transplantation Reducing Mortality in Adults With Advanced HIV Disease (REVIVE) NCT05580666Phase 352 sites📍 Abidjan📍 Abidjan📍 Abidjan Population Health Research Institute · Tests: Azithromycin Oral Tablet, Placebo oral tablet Mitochondrial Disease-associated ImmunoDeficiencies NCT06213103n/a2 sites📍 Bordeaux📍 Toulouse University Hospital, Bordeaux · Tests: Patient cohort, Control cohort
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy